跳转至内容
Merck
CN
  • Supplementation with omega-3 fatty acids during gestation and lactation to a vitamin B12-deficient or -supplemented diet improves pregnancy outcome and metabolic variables in Wistar rats.

Supplementation with omega-3 fatty acids during gestation and lactation to a vitamin B12-deficient or -supplemented diet improves pregnancy outcome and metabolic variables in Wistar rats.

Reproduction, fertility, and development (2013-12-21)
Amrita Khaire, Richa Rathod, Nisha Kemse, Anvita Kale, Sadhana Joshi
摘要

Maternal vitamin B12 deficiency leads to an adverse pregnancy outcome and increases the risk for developing diabetes and metabolic syndrome in mothers in later life. Our earlier studies have demonstrated that vitamin B12 and n-3 polyunsaturated fatty acids (PUFA) are interlinked in the one carbon cycle. The present study for the first time examines the effect of maternal n-3 PUFA supplementation to vitamin B12 deficient or supplemented diets on pregnancy outcome, fatty-acid status and metabolic variables in Wistar rats. Pregnant dams were assigned to one of the following groups: control, vitamin B12 deficient, vitamin B12 supplemented, vitamin B12 deficient + n-3 PUFA or vitamin B12 supplemented + n-3 PUFA. The amount of vitamin B12 in the supplemented group was 0.50 μg kg(-1) diet and n-3 PUFA was alpha linolenic acid (ALA) 1.68, eicosapentaenoic acid 5.64, docosahexaenoic acid (DHA) 3.15 (g per 100g fatty acids per kg diet). Our findings indicate that maternal vitamin B12 supplementation did not affect the weight gain of dams during pregnancy but reduced litter size and weight and was ameliorated by n-3 PUFA supplementation. Vitamin B12 deficiency or supplementation resulted in a low percentage distribution of plasma arachidonic acid and DHA. n-3 PUFA supplementation to these diets improved the fatty-acid status. Vitamin B12 deficiency resulted in higher homocysteine and insulin levels, which were normalised by supplementation with either vitamin B12 or n-3 PUFA. Our study suggests that maternal vitamin B12 status is critical in determining pregnancy outcome and metabolic variables in dams and that supplementation with n-3 PUFA is beneficial.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
维生素 B 12, ≥98%
Supelco
维生素B12, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
胆固醇, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
维生素 B 12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
(L)-脱氢抗坏血酸
Sigma-Aldrich
SyntheChol ® NS0 补充, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Sigma-Aldrich
5-氨基乙酰丙酸盐 盐酸盐, ≥98%
Supelco
腈钴胺(维生素 B12), analytical standard
Sigma-Aldrich
胆固醇, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
5-氨基乙酰丙酸盐 盐酸盐, BioReagent, suitable for cell culture, powder, ≥98%
Supelco
胆固醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL-同型半胱氨酸, ≥95% (titration)
Supelco
胆固醇 溶液, certified reference material, 10 mg/mL in chloroform
Sigma-Aldrich
氰钴胺, meets USP testing specifications
Sigma-Aldrich
5-氨基乙酰丙酸盐 盐酸盐, ≥97.0% (AT)
Sigma-Aldrich
脱氢- L -(+)-抗坏血酸二聚体, ≥80% (enzymatic)
Supelco
DL-同型半胱氨酸, analytical standard
SAFC
胆固醇, from sheep wool, Controlled origin, meets USP/NF testing specifications
氰钴胺, British Pharmacopoeia (BP) Assay Standard
氰钴胺, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
胆固醇, tested according to Ph. Eur.